Titre : | Providing hepatitis B vaccination to injection drug users: referral to health clinics vs on-site vaccination at a syringe exchange program (2001) |
Auteurs : | D. C. DES JARLAIS ; D. G. FISHER ; J. C. NEWMAN ; TRUBATCH B. N. ; YANCOVITZ M. ; D. PAONE ; D. PERLMAN |
Type de document : | Article : Périodique |
Dans : | American Journal of Public Health (Vol.91, n°11, November 2001) |
Article en page(s) : | 1791-1792 |
Langues: | Anglais |
Discipline : | PRE (Prévention - RdRD / Prevention - Harm reduction) |
Mots-clés : |
Thésaurus mots-clés REDUCTION DES RISQUES ET DES DOMMAGES ; HEPATITE ; ECHANGE DE SERINGUES ; PROGRAMME ; PREVENTION DE PROXIMITE ; ETUDE LONGITUDINALE ; ENQUETEThésaurus géographique ETATS-UNIS |
Résumé : | Injection drug users (IDUs) are at very high risk for infection with hepatitis B virus (HBV) through multiperson use of injection equipment and through unprotected sexual contact. Although a safe and efficacious vaccine exists for hepatitis B, there are multiple problems in vaccinating IDUs in the United States, including (1) discrimination against drug users by health care providers, (2) the need to reach IDUs before they are exposed to HBV, (3) paying for the vaccinations, and (4) difficulties in completing the 3-injection vaccination series. We compared 2 methods for delivering free hepatitis B vaccination to IDUs: (1) referral by research staff to local health care providers and (2) on-site vaccination at a syringe exchange program. (Extract of the publication) |
Domaine : | Drogues illicites / Illicit drugs |
Refs biblio. : | 4 |
Affiliation : | Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center, New York, NY 10003, USA |
Numéro Toxibase : | 1300253 |
Centre Emetteur : | 13 OFDT |
Lien : | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1446878/ |
Accueil